UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

TAVR Case Selection in the “Real World”: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Periprocedural Transaortic Valve LVOT Migration With Successful Reposition: "The Double-Snare Technique“